| abstract |
The present invention relates to a pharmaceutical, particularly a melanin-concentrating hormone receptor antagonist comprising a derivative having a nitrogen-containing heterocycle as a main skeleton or a pharmaceutically acceptable salt thereof as an active ingredient, more preferably an anti-obesity agent and the pharmaceutical. The present invention relates to a useful novel nitrogen-containing saturated heterocyclic ring, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof. |